Medikamentöse Schmerztherapie bei rheumatischen Erkrankungen

[1]  J. Gostomzyk,et al.  Langzeitanwendung von Betäubungsmitteln bei der Schmerztherapie , 2008 .

[2]  I. Pichlmayr,et al.  Opioidanalgetika bei “nichtmalignen” Schmerzen—Langzeitbehandlungsergebnisse bei Patienten mit rheumatischen Beschwerden , 1991, Der Schmerz.

[3]  K. Resch.  Der entzündliche Gelenkschmerz , 1991, Der Schmerz.

[4]  H. Mathies.  Die Schmerztherapie bei rheumatischen Gelenk-und Wirbelsäulenerkrankungen , 1990, Der Schmerz.

[5]  M. Zenz,et al.  Orale Opiattherapie bei Patienten mit “nicht-malignen” Schmerzen , 1990, Der Schmerz.

[6]  T. Reisine.  Opioid analgesics and antagonists , 1996 .

[7]  S. Shapiro,et al.  Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study , 1991, Clinical pharmacology and therapeutics.

[8]  N. Coyle,et al.  Controversies in the long-term management of analgesic therapy in patients with advanced cancer. , 1990, Journal of palliative care.

[9]  F. Brescia,et al.  Clinitron therapy and pain management in advanced cancer patients. , 1990, Journal of pain and symptom management.

[10]  R. Portenoy.  Chronic opioid therapy in nonmalignant pain. , 1990, Journal of pain and symptom management.

[11]  Russell K. Portenoy,et al.  Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases , 1986, Pain.

[12]  Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. , 1986, JAMA.

[13]  Joseph B. Martin,et al.  Drug Therapy of Neuropathic Pain , 1985 .

[14]  A. Taub.  Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin , 1984, PAIN.

[15]  H. Jick,et al.  Addiction rare in patients treated with narcotics. , 1980, The New England journal of medicine.